Investigation of Repeatability of Peak Nasal Inspiratory Flow Rate Measurements Under Baseline Conditions and After Administration of 0.05% Oxymetazoline

1. Kahana-Zweig R, Geva-Sagiv M, Weissbrod A, Secundo L, Soroker N, Sobel N. Measuring and characterizing the human nasal cycle. PLoS One. 2016; 11(10):e0162918.
Google Scholar | Crossref | Medline2. Ottaviano G, Scadding GK, Iacono V, Scarpa B, Martini A, Lund VJ. Peak nasal inspiratory flow and peak expiratory flow. Upright and sitting values in an adult population. Rhinology. 2016; 54(2):160–163.
Google Scholar | Crossref | Medline3. Ottaviano, G, Pendolino, AL, Nardello, E, et al. Peak nasal inspiratory flow measurement and visual analogue scale in a large adult population. Clin Otolaryngol. 2019; 44:541–548.
Google Scholar | Crossref | Medline4. Ottaviano, G, Lund, VJ, Nardello, E, et al. Comparison between unilateral PNIF and rhinomanometry in healthy and obstructed noses. Rhinology. 2014; 52:25–30.
Google Scholar | Crossref | Medline5. Scadding, GW, Calderon, MA, Bellido, V, et al. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods. 2012; 384:25–32.
Google Scholar | Crossref | Medline6. Rimmer J, Greenwood A, Bartlett D, Hellgren J. Nasal steroids improve regulation of nasal patency in asthma and mild rhinitis: a randomised, cross-over trial. Eur Arch Otorhinolaryngol. 2012; 269:1133–1138.
Google Scholar | Crossref | Medline7. Rimmer, P, Hellings, P, Lund, VJ, et al. European position paper on diagnostic tools in rhinology. Rhinology. 2019; 57:1–41.
Google Scholar | Crossref | Medline8. Auge, J, Vent, J, Agache, I, et al. EAACI position paper on standardization of nasal allergen challenges. Allergy. 2018; 73:1597–1608.
Google Scholar | Crossref | Medline9. Klossek JM, Lebreton JP, Delagranda A, Dufour X. PNIF measurement in a healthy french population. A prospective study about 234 patients. Rhinology. 2009; 47:389–392.
Google Scholar | Medline10. da Cunha Ibiapina C, Ribeiro de Andrade C, Moreira Camargos PA, Goncalves Alvim C, Augusto Cruz A. Reference values for peak nasal inspiratory flow in children and adolescents in Brazil. Rhinology. 2011; 49:304–308.
Google Scholar | Crossref | Medline11. Van Spronsen, E, Ebbens, FA, Fokkens, WJ. Normal peak nasal inspiratory flow rate values in healthy children aged 6 to 11 years in The Netherlands. Rhinology. 2012; 50:22–25.
Google Scholar | Crossref | Medline12. Ottaviano G, Scadding GK, Coles S, Lund VJ. Peak nasal inspiratory flow; normal range in adult population. Rhinology. 2006; 44:32–35.
Google Scholar | Medline13. Papachristou, A, Bourli, E, Aivazi, D, et al. Normal peak nasal inspiratory flow rate values in Greek children and adolescents. Hippokratia. 2008; 12:94–102.
Google Scholar | Medline14. Dor-Wojnarowska A, Rabski M, Fal AM, Liebhart J, Panaszek B, Samolinski B. An attempt to estimate potentially useful parameters to evaluate the normal range of nasal peak inspiratory flow. Pneumonol Alergol Pol. 2011; 79:320–325.
Google Scholar | Medline15. Chaves C, Ibiapina Cda C, Ribeiro de Andrade C, Godinho R, Goncalves Alvim C, Augusto Cruz A. Correlation between peak nasal inspiratory flow and peak expiratory flow in children and adolescents. Rhinology. 2012; 50:381–385.
Google Scholar | Crossref | Medline16. Siroux, V, Boudier, A, Anto, JM, et al. Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy. 2008; 63:547–554.
Google Scholar | Crossref | Medline17. Fernández Benítez, M, Guillén, F, Marín, B, et al. International study of asthma and allergies in childhood. Results of the first phase of the I.S.A.A.C. project in pamplona, Spain. J Investig Allergol Clin Immunol. 1996; 6:288–293.
Google Scholar | Medline18. Vogt K, Bachmann-Harildstad G, Lintermann A, Nechyporenko A, Peters F, Wernecke KD. The new agreement of the international Riga consensus conference on nasal airway function tests. Rhinology. 2018; 56:133–143.
Google Scholar | Crossref | Medline19. Ottaviano, G, Fokkens, WJ. Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice. Allergy. 2016; 71:162–174.
Google Scholar | Crossref | Medline20. Starling-Schwanz, R, Peake, HL, Salome, CM, et al. Repeatibility of peak nasal inspiratory flow measurements and utility for assessing the severity of rhinitis. Allergy. 2005; 60(6):795–800.
Google Scholar | Crossref | Medline21. Vaidyanathan S, Nair A, Barnes L, Meldrum K, Lipworth BJ. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. Clin Exp Allergy. 2009; 39(3):409–416.
Google Scholar | Crossref | Medline22. Wilson A, Dempsey OJ, Sims EJ, Coutie WJ, Paterson MC, Lipworth BJ. Evaluation of treatment response in patient with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy. 1999; 30:833–838.
Google Scholar23. Valero, A, Navarro, AM, Del Cuvillo, A, et al. Position paper on nasal obstruction: evaluation and treatment. J Invest Allergy Clin Immunol. 2018; 28:67–90.
Google Scholar | Crossref | Medline24. Pellegrino, R, Viegi, G, Brusasco, V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26:948–968.
Google Scholar | Crossref | Medline25. Vaidyanathan S, Williamson P, Clearie K, Morrison A, Lipworth B. Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2011; 127(1):173–117.
Google Scholar

留言 (0)

沒有登入
gif